SCHEMBL7835308

SCHEMBL7835308

CNc1nc(-c2ccccc2)ccc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GALR2 O43603 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
PTPN1 P18031 1/20 0.45
TDP1 Q9NUW8 3/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 2/20 0.43
GLA P06280 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
MAPT P10636 4/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
GSK3B P49841 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11235404 0.86 POLB (0.45) GALR2LMNAPOLBPTPN1ALDH1A1
SCHEMBL3652564 0.84 KDR (0.46) GALR2LMNAPOLBPTPN1TDP1
SCHEMBL12100934 0.83 GSK3B (0.57) TDP1ALDH1A1GAAL3MBTL1MEN1
SCHEMBL8699458 0.79 MAPT (0.51) LMNAALDH1A1KDM4EMEN1KMT2A
SCHEMBL6614664 0.79 ALDH1A1 (0.51) TDP1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL20571494 0.77 ERN1 (0.43) GALR2LMNAPOLBPTPN1MAPT
SCHEMBL15724492 0.77 KMT2A (0.51) LMNAPOLBTDP1ALDH1A1KDM4E
SCHEMBL27524748 0.77 KDM4E (0.44) GALR2LMNAPOLBPTPN1TDP1
SCHEMBL31455452 0.76 ABCG2 (0.39) PTPN1TDP1ALDH1A1KDM4EGAA
SCHEMBL4663094 0.76 ALDH1A1 (0.46) TDP1ALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed